Search

Bharath Balu Phones & Addresses

  • 4055 Buchanan Trl W, Greencastle, PA 17225
  • Oakland, CA
  • Harrisonburg, VA
  • 5125 Palm Springs Blvd #3206, Tampa, FL 33647 (574) 232-7131
  • 3107 Remington Ct, Mishawaka, IN 46545 (574) 255-2584
  • 3107 Remington Ct #C, Mishawaka, IN 46545
  • South Bend, IN
  • Notre Dame, IN
  • Pomeroy, WA

Work

Company: Stanford research institute (sri) international - Harrisonburg, VA Feb 2011 Position: Research scientist

Education

School / High School: Wake Forest University- Winston-Salem, NC 2013 Specialities: MMS in ; Physician Assistant

Resumes

Resumes

Bharath Balu Photo 1

Bharath Balu

View page
Bharath Balu Photo 2

Bharath Balu Greencastle, PA

View page
Work:
Stanford Research Institute (SRI) International
Harrisonburg, VA
Feb 2011 to Feb 2013
Research Scientist

Education:
Wake Forest University
Winston-Salem, NC
2013 to 2015
MMS in ; Physician Assistant

University of Notre Dame
South Bend, IN
1999 to 2005
Ph.D. in Infectious Disease

Publications

Us Patents

Method And Composition Using A Dual Specificity Protein Tyrosine Phosphatase As An Antimalarial Drug Target

View page
US Patent:
20120077869, Mar 29, 2012
Filed:
Sep 20, 2011
Appl. No.:
13/237525
Inventors:
John H. Adams - Tampa FL, US
Bharath Balu - Harrisonburg VA, US
Steven P. Maher - Tampa FL, US
Christopher O. Campbell - Tampa FL, US
Roman Manetsch - Tampa FL, US
Assignee:
UNIVERSITY OF SOUTH FLORIDA - Tampa FL
International Classification:
A61K 31/5377
A61K 31/122
A61K 31/7088
A61K 31/403
A61P 33/06
A61K 31/655
A61K 31/4365
US Classification:
514 44 R, 5142352, 514150, 514681, 514301, 514411
Abstract:
Phosphotyrosine phosphatase (PTP) encoded by PF13_0027 is a desirable drug target for the human malaria parasite . This PTP is critical for intraerythrocytic parasite development and invasion of erythrocytes by malaria merozoites. Mutation of the PF13_0027 gene or blocking expression of PTP function to create a PTP-null parasite severely attenuates the malaria parasite's ability to survive, making the PTP-null parasite suitable as an attenuated blood-stage parasite vaccine.

High Efficiency Transformation Of By The Lepidopteran Transposon,

View page
US Patent:
7932088, Apr 26, 2011
Filed:
Apr 25, 2006
Appl. No.:
11/410333
Inventors:
John H. Adams - Granger IN, US
Malcolm J. Fraser - Granger IN, US
Bharath Balu - South Bend IN, US
Douglas A. Shoue - North Liberty IN, US
Assignee:
University of Notre Dame du Lac - Notre Dame IN
International Classification:
C12N 15/74
C12N 15/82
C12N 15/87
A01H 1/00
US Classification:
435473, 800291
Abstract:
The present invention provides molecular methods for efficiently transforming the genome of common disease-transmitting parasites, such as. The transformation efficiencies are improved up to 100 times over those conventionally known. The methods provide high saturation of the target parasite genome, of 50% or greater, and target non-specifically TTAA-rich sites in the parasite genome. The invention also discloses a model that may be used to functionally annotate the genome of the , thus permitting the design and screening of compounds that may be useful in the control and inhibiting of diseases caused and transmitted by these parasites, including malaria. Highly efficient and multi-site integrating transposons, particularly piggyBac transposons, which provide for random and multi-site integration into parasite genomes in the presence of a helper plasmid, are also presented.
Bharath Caitlin Bharath Balu from Greencastle, PA, age ~46 Get Report